US Pharma Stocks Slide Amid Trump’s Tariff Comments
Date: April 9, 2025
What Happened?
Major US pharmaceutical companies such as Pfizer, Johnson & Johnson, and Amgen experienced stock price declines at the US market open following fears of renewed tariffs. This was triggered by comments from former President Donald Trump indicating potential future trade penalties on pharmaceutical imports, especially from China.
Key Companies Affected:
- Pfizer Inc.: Dropped over 3% on NYSE
- Johnson & Johnson: Fell nearly 2%
- Amgen: Down 2.5% intraday
Reason Behind the Fall
Trump's remarks on favoring domestic pharmaceutical production and his warning on dependency on foreign-made drugs sparked concerns of retaliatory tariffs or new regulations, which would impact profitability of US drugmakers.
Market Impact
- Investors rotated out of pharma and biotech stocks
- Healthcare sector ETFs like XLV saw red
- Concerns over supply chain disruption and pricing pressure
Conclusion
The uncertainty around pharmaceutical policy and trade tariffs continues to create volatility. Investors may need to monitor policy developments closely, especially during the US election cycle.
Comments
Post a Comment